ArticleFrontiers in medicine2023

Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome.

Florence Roufosse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.